Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price reached a new 52-week low on Monday . The stock traded as low as GBX 14 ($0.18) and last traded at GBX 18 ($0.23), with a volume of 368579 shares. The stock had previously closed at GBX 28 ($0.35).
Celadon Pharmaceuticals Stock Performance
The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 194.82. The stock has a fifty day moving average price of GBX 31.53 and a two-hundred day moving average price of GBX 55.68. The company has a market capitalization of £12.39 million, a price-to-earnings ratio of -350.00 and a beta of -0.26.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- What is the NASDAQ Stock Exchange?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Short Selling: How to Short a Stock
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
